Kotha Anil Kumar

480 total citations
12 papers, 366 citations indexed

About

Kotha Anil Kumar is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Kotha Anil Kumar has authored 12 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Complementary and alternative medicine. Recurrent topics in Kotha Anil Kumar's work include Inflammatory mediators and NSAID effects (4 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Banking Sector Performance and Management (2 papers). Kotha Anil Kumar is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Banking Sector Performance and Management (2 papers). Kotha Anil Kumar collaborates with scholars based in India and France. Kotha Anil Kumar's co-authors include Pallu Reddanna, Lakshmipathi Vadlakonda, Mukesh Pasupuleti, Dowlathabad Muralidhara Rao, Gangappa Dharmapuri, Gundala Harold Philip, Syed M. Faisal, T. Chandramohan Reddy, Suresh K. Kalangi and Sasikumar J. Soumya and has published in prestigious journals such as Scientific Reports, Frontiers in Oncology and Inflammation Research.

In The Last Decade

Kotha Anil Kumar

10 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kotha Anil Kumar India 9 175 57 52 41 37 12 366
Maikho Thoh India 10 238 1.4× 49 0.9× 51 1.0× 62 1.5× 33 0.9× 17 431
Nagaraj M. Kulkarni India 13 151 0.9× 34 0.6× 47 0.9× 57 1.4× 26 0.7× 19 410
Shirin Amiri Moghadam Iran 7 185 1.1× 35 0.6× 28 0.5× 31 0.8× 46 1.2× 10 452
Woo-Kwang Jeon South Korea 12 347 2.0× 93 1.6× 31 0.6× 47 1.1× 52 1.4× 15 551
Qingyu Zhang China 13 198 1.1× 70 1.2× 47 0.9× 45 1.1× 47 1.3× 27 454
Yong‐Zhan Zhen China 14 212 1.2× 54 0.9× 45 0.9× 33 0.8× 37 1.0× 31 482
Ramakrishna Chintala India 4 220 1.3× 71 1.2× 33 0.6× 24 0.6× 88 2.4× 7 431
Sivalokanathan Sarveswaran United States 10 172 1.0× 83 1.5× 113 2.2× 28 0.7× 59 1.6× 14 437
Govinda Rao Duddukuri India 8 221 1.3× 83 1.5× 38 0.7× 37 0.9× 83 2.2× 14 453
Larissa Akemi Kido Brazil 14 195 1.1× 63 1.1× 21 0.4× 18 0.4× 52 1.4× 37 466

Countries citing papers authored by Kotha Anil Kumar

Since Specialization
Citations

This map shows the geographic impact of Kotha Anil Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kotha Anil Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kotha Anil Kumar more than expected).

Fields of papers citing papers by Kotha Anil Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kotha Anil Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kotha Anil Kumar. The network helps show where Kotha Anil Kumar may publish in the future.

Co-authorship network of co-authors of Kotha Anil Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Kotha Anil Kumar. A scholar is included among the top collaborators of Kotha Anil Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kotha Anil Kumar. Kotha Anil Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kumar, Kotha Anil, et al.. (2023). Artificial Intelligence Advances and Their Repercussions on the Financial System. 1–4. 3 indexed citations
2.
Kumar, Kotha Anil, et al.. (2021). Overview on the Discovery and Development of Anti-Inflammatory Drugs: Should the Focus Be on Synthesis or Degradation of PGE2?. Journal of Inflammation Research. Volume 14. 253–263. 76 indexed citations
3.
Kumar, Kotha Anil, et al.. (2019). Digitalization impact on banking operational profitability with reference to public and private sector banks. International Journal of Management, IT, and Engineering. 9(1). 252–265.
4.
Kumar, Kotha Anil, et al.. (2018). Financial Performance of State Bank of India with Reference to Deposits and Advances-A Study. Asian Journal of Management. 9(4). 1342–1342.
5.
Kumar, Kotha Anil, et al.. (2017). Mangiferin from Pueraria tuberosa reduces inflammation via inactivation of NLRP3 inflammasome. Scientific Reports. 7(1). 42683–42683. 60 indexed citations
6.
Rammohan, Aluru, Duvvuru Gunasekar, Kotha Anil Kumar, et al.. (2015). Isoorientin, a Selective Inhibitor of Cyclooxygenase-2 (COX-2) from the Tubers of Pueraria tuberosa. Natural Product Communications. 10(10). 1703–4. 14 indexed citations
7.
Vadlakonda, Lakshmipathi, et al.. (2013). The Paradox of Akt-mTOR Interactions. Frontiers in Oncology. 3. 165–165. 116 indexed citations
8.
Vadlakonda, Lakshmipathi, et al.. (2013). Did We Get Pasteur, Warburg, and Crabtree on a Right Note?. Frontiers in Oncology. 3. 186–186. 8 indexed citations
9.
Soumya, Sasikumar J., et al.. (2012). Effect of 15-lipoxygenase metabolites on angiogenesis: 15(S)-HPETE is angiostatic and 15(S)-HETE is angiogenic. Inflammation Research. 61(7). 707–718. 28 indexed citations
10.
Kumar, Kotha Anil, T. Chandramohan Reddy, Gorla V. Reddy, et al.. (2011). High-throughput screening assays for cyclooxygenase-2 and 5-lipoxygenase, the targets for inflammatory disorders.. PubMed. 48(4). 256–61. 17 indexed citations
11.
Reddy, T. Chandramohan, et al.. (2010). Kinetics and Docking Studies of a COX-2 Inhibitor Isolated from Terminalia bellerica Fruits. Protein and Peptide Letters. 17(10). 1251–1257. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026